Covaxin, bharat biotech, sec, covid 19, bharat biotech s covaxin, india, DCGI, Covaxin for emergency use in age group between 6-12 years, CDSCO, Hyderabad, Zydus Healthcare, Bharat Biotech, National Technical Advisory Group on Immunisation, Astra Zeneca vaccine, Covishield, Bharat Biotech, india
France has decided to share 670,000 doses of COVID-19 Astra Zeneca vaccine with Vietnam via the COVAX Facility, French President Emmanuel Macron wrote on Twitter on August 12.
PARIS, May 29 — The Pfizer vaccine is slightly less effective but appears to still protect against the more transmissible Indian strain of the virus that causes Covid-19, according to a study by France”s Pasteur Institute. “Despite slightly diminished efficacy, the Pfizer vaccine...
External Affairs Minister S Jaishankar also met influential American lawmakers from both the Democratic and Republican parties on Thursday and discussed developments pertaining to Quad and the cooperation on vaccines with them.
By Ralph Ellis
May 25, 2021 -- A study found that two doses of the Pfizer/BioNTech or the Astra/Zeneca vaccine protect against the COVID-19 variant first detected in India -- as well as the variant first found in the United Kingdom.
The study emphasized the need for two doses, saying one dose of the vaccines provided much less protection.
The Public Health England study looked at health data from 1,054 people of different ages and ethnicities in April and May.
The study said the Pfizer vaccine was 88% effective against the B.1.617.2 variant, first found in India, 2 weeks after the second dose. The Pfizer vaccine was 93% effective against the variant found in the U.K., known as B.1.1.7, two weeks after the second dose.